Novavax stock is poised for a massive short squeeze in 2024, with analysts predicting explosive growth due to its COVID vaccine delivery projections. Investors like Martyn Lucas are bullish on NVAX, citing fundamental and technical analysis. Stay tuned for updates on this promising stock as it continues to rise.